Consistently, neutralization of TRAIL is associated with rescue from the death of human neurons challenged in vitro with Aβ, as well as with reduced Aβ burden, significant functional recovery, and a restrain of immune/inflammatory response overshoot and consequent tissue damage in a triple transgenic mouse model of AD [10,11,12]. This evidence concerns the gene TNFSF10 and Alzheimer disease.